BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Lupin Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500257
ISIN Demat
INE326A01037
Book Value (Rs)
595.6712081
NSE Symbol
LUPIN
Divident Yield %
0.51
Market Cap
(Rs In Cr.)
106,601
P/E (TTM)
19.28
EPS (TTM)
120.99
Face Value
(Rs)
2
Date Heading
27-Feb-26 Lupin receives EIR report with VAI classification for its Goa unit
27-Feb-26 Lupin gets satisfactory USFDA inspection report for Goa facility
25-Feb-26 Lupin gets USFDA nod for Brivaracetam Oral Solution
25-Feb-26 Lupin receives USFDA approval for Brivaracetam Oral Solution 10 mg/mL
25-Feb-26 Lupin Ltd spurts 1.61%
24-Feb-26 Lupin secures European Commission approval for Ranluspec
23-Feb-26 Lupin receives European Commission approval for Biosimilar Ranibizumab
17-Feb-26 Stock Alert: Lupin, NTPC, Cochin Shipyard, Texmaco Rail & Engineering,
17-Feb-26 Lupin rises on licensing pact with Spektus Pharma for DeslaFlex in Can
13-Feb-26 Lupin consolidated net profit rises 37.47% in the December 2025 quarter
13-Feb-26 Lupin Q3 PAT soars 37% YoY to Rs 1,176 crore
13-Feb-26 Lupin allots 75,273 equity shares under ESOP
10-Feb-26 Lupin settles patent dispute with Astellas
02-Feb-26 Lupin announces strategic collaboration with TB Alliance
02-Feb-26 Lupin launches Dasatinib Tablets in U.S. market
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)